Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1274, 2001-01, pp. : 7-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Omiganan comes up roses for rosacea
Inpharma, Vol. 1, Iss. 1611, 2007-01 ,pp. :
Pexelizumab: lower MI, mortality rates after CABG
Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. :
Disheartening results for pexelizumab in acute STEMI
Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. :
Pexelizumab: reduced mortality rate after acute MI
Inpharma, Vol. 1, Iss. 1373, 2003-01 ,pp. :
Preoperative -blocker use beneficial in CABG
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. :